This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.
5/5/2022
Rob
this year through our European colleagues.
Unknown Analyst
Got it. And then my quick follow-up is, just beyond renal transplant, will conditioning be required for CAR-T reg therapies and other chronic disease indications in either autologous or allogeneic settings?
Rob
Well, depending on the cell therapy, preconditioning is required for, I think, everything that's been required preparation of the bone marrow for the engraftment. I don't know of any examples where preconditioning has not been used. There are a number of preconditioning protocols, so there's constant work to reduce the patient burden with respect to that preconditioning. But in order to ensure adequate engraftment, typically these are being used.
You're reading a preview of the SGMO Q1 2022 earnings call.
Free account.
Disclaimer